# Caretrust Reit (CTRE) — Analyst Forecast

CTRE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/ctre/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 12 | 2 | 0 | 14 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $42.00 | $43.50 | $45.00 | 6 |

Last price $36.59 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | UBS | Maintained | Buy | $44.00 |
| Oct 5, 2026 | BMO Capital | Maintained | Outperform | $45.00 |
| Oct 5, 2026 | RBC Capital | Maintained | Sector Perform | $43.00 |
| Oct 5, 2026 | Raymond James | Maintained | Outperform | $42.00 |
| Sep 1, 2026 | Wells Fargo | Maintained | Overweight | $44.00 |
| Aug 14, 2026 | RBC Capital | Downgraded | Outperform → Sector Perform | $43.00 |
| Aug 10, 2026 | Cantor Fitzgerald | Maintained | Neutral | $43.00 |
| Jun 17, 2026 | Raymond James | Maintained | Strong Buy → Outperform | $43.00 |
| Jun 15, 2026 | BMO Capital | Maintained | Outperform | $47.00 |
| Jun 1, 2026 | Wells Fargo | Maintained | Overweight | $47.00 |
| Apr 2, 2026 | Mizuho | Initiated Coverage | Outperform | $42.00 |
| Mar 26, 2026 | Wells Fargo | Maintained | Overweight | $42.00 |
| Feb 24, 2026 | RBC Capital | Maintained | Outperform | $44.00 |
| Feb 18, 2026 | UBS | Maintained | Buy | $48.00 |
| Feb 17, 2026 | Cantor Fitzgerald | Maintained | Neutral | $42.00 |
| Jan 22, 2026 | Citizens | Initiated Coverage | Market Outperform | $44.00 |
| Jan 9, 2026 | BMO Capital | Upgraded | Market Perform → Outperform | $43.00 |
| Jan 8, 2026 | UBS | Maintained | Buy | $43.00 |
| Dec 16, 2025 | Jefferies | Maintained | Buy | $43.00 |
| Dec 4, 2025 | Keybanc | Maintained | Overweight | $40.00 |

## Frequently Asked Questions

### What is the price target for CTRE stock?

The average 12-month analyst price target for Caretrust Reit (CTRE) is $43.50, with a high estimate of $45.00 and a low of $42.00, across 6 analysts.

### Is CTRE a buy, sell, or hold?

Analysts covering Caretrust Reit currently average a Buy rating: 12 buy, 2 hold and 0 sell, from 14 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for CTRE?

The average price target of $43.50 implies 18.88% upside from the last price of $36.59.

### What is the latest analyst rating on CTRE?

On Oct 13, 2026, UBS maintained Caretrust Reit at Buy with a price target of $44.00.

## Similar Stocks

- [OHI](https://www.lighthorse.io/tickers/ohi) — Omega Healthcare Investors, Inc. Common Stock
- [SBRA](https://www.lighthorse.io/tickers/sbra) — Sabra Health Care REIT, Inc. - Common Stock
- [NHI](https://www.lighthorse.io/tickers/nhi) — National Health Investors, Inc. Common Stock
- [LTC](https://www.lighthorse.io/tickers/ltc) — LTC Properties, Inc. Common Stock
- [WELL](https://www.lighthorse.io/tickers/well) — Welltower Inc. Common Stock
- [VTR](https://www.lighthorse.io/tickers/vtr) — Ventas, Inc. Common Stock
- [AHR](https://www.lighthorse.io/tickers/ahr) — American Healthcare REIT, Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).